IL325522A - Methods for treating atrial fibrillations with budiodarone - Google Patents
Methods for treating atrial fibrillations with budiodaroneInfo
- Publication number
- IL325522A IL325522A IL325522A IL32552225A IL325522A IL 325522 A IL325522 A IL 325522A IL 325522 A IL325522 A IL 325522A IL 32552225 A IL32552225 A IL 32552225A IL 325522 A IL325522 A IL 325522A
- Authority
- IL
- Israel
- Prior art keywords
- budiodarone
- methods
- treating atrial
- atrial fibrillations
- fibrillations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363525093P | 2023-07-05 | 2023-07-05 | |
| PCT/US2023/027521 WO2025010071A1 (en) | 2023-07-05 | 2023-07-12 | Methods for treating atrial fibrillations with budiodarone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325522A true IL325522A (en) | 2026-02-01 |
Family
ID=87553572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325522A IL325522A (en) | 2023-07-05 | 2025-12-22 | Methods for treating atrial fibrillations with budiodarone |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR20260033540A (en) |
| CN (1) | CN121693328A (en) |
| AU (1) | AU2023453395A1 (en) |
| IL (1) | IL325522A (en) |
| MX (1) | MX2026000037A (en) |
| WO (1) | WO2025010071A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11759640B2 (en) | 2022-01-07 | 2023-09-19 | Xyra, Llc | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9549912B2 (en) | 2009-11-23 | 2017-01-24 | Armetheon, Inc. | Methods for treating atrial fibrillation |
| EP2968256A4 (en) * | 2013-03-13 | 2017-03-22 | Armetheon, Inc. | Budiodarone formulations |
| WO2023133510A1 (en) * | 2022-01-07 | 2023-07-13 | Xyra, Llc | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations |
| US20230372284A1 (en) * | 2022-01-07 | 2023-11-23 | Xyra, Llc | Methods for treating atrial fibrillations |
-
2023
- 2023-07-12 AU AU2023453395A patent/AU2023453395A1/en active Pending
- 2023-07-12 WO PCT/US2023/027521 patent/WO2025010071A1/en active Pending
- 2023-07-12 KR KR1020267001615A patent/KR20260033540A/en active Pending
- 2023-07-12 CN CN202380101190.3A patent/CN121693328A/en active Pending
-
2025
- 2025-12-22 IL IL325522A patent/IL325522A/en unknown
-
2026
- 2026-01-07 MX MX2026000037A patent/MX2026000037A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025010071A1 (en) | 2025-01-09 |
| KR20260033540A (en) | 2026-03-10 |
| CN121693328A (en) | 2026-03-17 |
| AU2023453395A1 (en) | 2026-02-19 |
| MX2026000037A (en) | 2026-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3924490A4 (en) | Methods for treating cholestasis | |
| EP4086346A4 (en) | Method for treating usher syndrome and composition thereof | |
| IL325522A (en) | Methods for treating atrial fibrillations with budiodarone | |
| EP2280675A4 (en) | Apparatus and method for preventing brain damage during cardiac arrest, cpr, or severe shock | |
| IL286653A (en) | Methods for treating muscular dystrophy with casimersen | |
| EP3931336A4 (en) | Compositions and methods for treating laminopathies | |
| EP3760700B8 (en) | Process for treating wort | |
| IL285094A (en) | Methods for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments | |
| EP4363057A4 (en) | Methods for treating depressive states | |
| EP3909360A4 (en) | Method and apparatus for two-step random access procedure | |
| IL287981A (en) | Compositions and methods for treating t cell exhaustion | |
| EP3976042A4 (en) | Methods of treating cholangiocarcinoma | |
| EP4297875A4 (en) | Methods for treating multiple myeloma | |
| CA3297230A1 (en) | Methods for treating atrial fibrillations with budiodarone | |
| EP4003390A4 (en) | Method for treating solid tumors | |
| AU2024217776A1 (en) | Methods for treating glioblastoma | |
| EP4400576A4 (en) | Method for treating cells | |
| HUP2100153A1 (en) | Heating panel, treatment equipment, and method for wood treatment | |
| HK40104573A (en) | Methods for treating covid-19 with sepiapterin | |
| GB201903259D0 (en) | Systems and methods for treating cardiac arrhythmia | |
| HK40089794A (en) | Methods for treating covid-19 | |
| CA3279090A1 (en) | Methods for treating metabolic syndrome | |
| EP4051214A4 (en) | Method for treating skin | |
| IL316036A (en) | Methods for treating lysosomal storage diseases | |
| HK40092015A (en) | Methods for treating depression |